在固体瘤中对子宫内糖氨酸糖具有特异性的过渡性CAR-T细胞
Nastaran Khazamipour1,2, Htoo Zarni Oo1,2,3, Nader Al-Nakouzi1,2
1Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
EMBO molecular medicine
|October 15, 2024
概括
研究人员开发了针对癌症特异性ondroitin硫酸盐 (CS) 的仿真抗原受体 (CAR) T细胞. 这些CAR-T细胞装备了特定的莱克,在体外和体内有效地消除了瘤,显示出免疫治疗的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 葡萄糖氨基甘氨酸 (GAG) 由于其复杂的葡萄糖表位 (glyco-epitopes) 是具有挑战性的免疫治疗点.
- 胎冠状素硫酸盐 (CS) 在固体瘤上表达,但通常仅限于胎盘.
研究的目的:
- 设计和评估化抗原受体 (CAR) 的T细胞,以向胎儿CS.
- 评估VAR2CSA-lectin-armed CAR T细胞对表达子宫CS的瘤的疗效.
主要方法:
- 转移性CAR T细胞的发展,具有针对子宫内CS的特异性.
- 用复合VAR2CSA学蛋白 (rVAR2) 武装CAR T细胞以向瘤细胞.
- 在体外和体内对CAR T细胞激活,细胞毒性和抗瘤作用的评估.
主要成果:
- 在实验室中,VAR2武装的CAR T细胞表现出强大的激活,并消除了各种瘤细胞类型.
- 通过rVAR2.2的度来调整CAR T细胞细胞毒性.
- 在体内研究表明,武装的CAR T细胞向膀瘤,并改善小鼠的生存率.
结论:
- 携带rVAR2的过渡性CAR-T细胞可以有效地向和消除表达胎儿CS的瘤.
- 癌症受限的GAG代表了基于CAR T细胞的新型免疫疗法的可行目标.
相关概念视频
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857


